Burkina Faso

in page functions
[French]
Burkina Faso
Total population (2017) 19,173,317
Birth cohort (2017) 741,830
Surviving Infants (surviving to 1 year per year, 2017) 698,043
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 61/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 89/1000
World Bank Index, IDA (2015) 3.61
Gross Nation Income (per capita US$, 2015) 640
Co-financing group (2018) Initial self-financing
No. of districts/territories (2016) 70

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Burkina Faso

Type of support

Approvals

2001-2022 (US$)
(29 May 2018)

Commitments

2001-2022 (US$)
(29 May 2018)

Disbursements

2000-2018 (US$)
(29 May 2018)

% Disbursed

(29 May 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $210,061,210 $254,172,210 $204,462,878
Cash Support (CASHSUPP) $145,000 $170,000 $145,000 100%
Health system strengthening (HSS 1) $4,978,500 $4,978,500 $4,978,500 100%
Health system strengthening (HSS 2) $4,436,347 $4,436,347 $4,436,347 100%
Health system strengthening (HSS 3) $5,040,000 $11,760,000
HPV Demo (NVS) $189,506 $189,506 $190,622 101%
Immunisation services support (ISS) $9,705,605 $9,705,605 $9,705,605 100%
Injection Safety Devices (NVS) $628,479 $1,192,479 $746,203 119%
Injection safety support (INS) $931,560 $931,560 $931,560 100%
IPV (NVS) $757,679 $757,679 $343,829 45%
Measles (NVS) $1,218,229 $1,218,229 $910,729 75%
Measles-Rubella (NVS) $6,000,965 $6,000,965 $6,000,965 100%
Meningitis A (NVS) $960,871 $1,839,371 $1,013,958 106%
Meningitis A - mini catch-up campaign (NVS) $3,134,671 $3,134,671 $3,134,671 100%
Meningitis A - mini catch-up op.costs (OPC) $2,571,802 $2,571,802 $2,571,802 100%
MR - Operational costs (OPC) $4,925,847 $4,925,847 $4,925,847 100%
Penta (NVS) $63,816,939 $66,348,439 $64,389,968 101%
Pneumo (NVS) $54,151,163 $71,524,663 $56,157,143 104%
Product Switch Grant (PSG) $194,286 $194,286
Rotavirus (NVS) $42,715,267 $58,733,767 $40,321,635 94%
Vaccine Introduction Grant (VIG) $3,558,494 $3,558,494 $3,558,494 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Burkina Faso DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 91%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2009) 90.30%
Household survey: DTP3 coverage for female (2009) 88.80%
Household survey: Last DTP3 survey (2009) 90%
% districts achieving > 80% DTP3 coverage (2016) 100%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 88%

Breakdown of support

Non-vaccine support Vaccine support
15% 85%
$31,253,155 $173,209,723

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Burkina Faso

25 April 2017

Central African Republic, a mother and her two children.

Central African Republic: mother spreads word about meningitis A vaccine

Izimili Raude knows that her community must rely on vaccines, not miracles, to spare children from a deadly disease.

27 July 2016

First Sudanese child to receive Meningitis A vaccine as part of routine immunization.

Sudan: first to introduce life-saving meningitis A vaccine into routine immunization

Children in Sudan are set to become the first in the Meningitis belt to benefit from the introduction of Meningitis A vaccine into a routine immunization programme.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

close icon

modal window here